Latest updates for Zint:ca

Fresh curated links around ZINT:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Philip Morris International Inc. 2026 Q3 - Results - Earnings Call Presentation
  • Zentalis at Morgan Stanley conference: azenosertib push gains shape
  • Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /3 days ago

Philip Morris International Inc. 2026 Q3 - Results - Earnings Call Presentation

Read source
investing.com /1 month ago

Zentalis at Morgan Stanley conference: azenosertib push gains shape

Read source
seekingalpha.com /1 month ago

Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Read source
seekingalpha.com /1 month ago

Zymeworks: Transitioning Into A Royalty-Driven Biopharma Platform Post Ziihera Approval

Read source
seekingalpha.com /2 days ago

Philip Morris International Inc. (PM) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Stocks to watch on Thursday after hours: INTA, XENE, PXED

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Zanvastro]]>

Read source
seekingalpha.com /1 month ago

How Lead, Silver And Copper Credits Are Reshaping Zinc Mine Profitability

Read source
prweb.com /1 week ago

Just Ingredients NAD+ Complex Features Compound Solutions' Newly Patented NAD3®

The daily longevity capsule pairs NAD3® with nicotinamide riboside and organic resveratrol, anchoring the formula in mitochondrial function rather than NAD+ levels alone. CARLSBAD...

Read source
seekingalpha.com /1 month ago

Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Zint:ca

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

investing.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source

prweb.com

Recent coverage from public sources
Public source